Researchers uncover genetic dosage key for African-American patients
Researchers have discovered a way to make a blood thinner safer for about 40 percent of African-Americans taking the drug by linking a common gene variation to the dose. These findings, published June 4 EDT in The Lancet, are the latest results from ongoing collaborative work by…